Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Feb 19, 2008

FDA Approves Xyzal® (Levocetirizine Dihydrochloride) Oral Solution For The Relief Of Seasonal And Year Round Allergies and Chronic Idiopathic Urticaria
Feb 13, 2008

Sanofi Pasteur Files for European Approval of the First Seasonal Influenza Vaccine Delivered by Intradermal Microinjection
Jan 14, 2008

Phase III Data Published For Once Monthly Dose Of Risedronate To Treat Postmenopausal Osteoporosis
Jan 4, 2008

Ambien CR® (zolpidem tartrate extended-release) tablets CIV Improved Chronic Insomnia in Patients with Co-Morbid Generalized Anxiety Disorder
Dec 10, 2007

Study Shows that Low-Molecular Weight Heparin (LMWH) Was Associated With Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractioned Heparin (UFH)

Patients treated with Lovenox® (enoxaparin sodium injection) were also less likely to be readmitted to hospital within 90 days

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.